Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Aug 23, 2023

SELL
$96.34 - $112.38 $96,340 - $112,380
-1,000 Reduced 27.03%
2,700 $277,000
Q1 2023

May 15, 2023

SELL
$107.32 - $113.5 $3.78 Million - $4 Million
-35,200 Reduced 90.49%
3,700 $404,000
Q4 2022

Feb 14, 2023

BUY
$62.39 - $113.8 $2.43 Million - $4.43 Million
38,900 New
38,900 $4.43 Million
Q2 2022

Aug 15, 2022

BUY
$79.4 - $116.36 $134,980 - $197,812
1,700 Added 16.83%
11,800 $974,000
Q1 2022

May 16, 2022

SELL
$86.42 - $109.81 $717,286 - $911,423
-8,300 Reduced 45.11%
10,100 $1.07 Million
Q4 2021

Feb 14, 2022

SELL
$98.56 - $119.91 $1.39 Million - $1.69 Million
-14,100 Reduced 43.38%
18,400 $1.99 Million
Q3 2021

Nov 12, 2021

BUY
$91.91 - $110.37 $1.19 Million - $1.42 Million
12,900 Added 65.82%
32,500 $3.57 Million
Q2 2021

Aug 06, 2021

SELL
$86.24 - $95.92 $974,512 - $1.08 Million
-11,300 Reduced 36.57%
19,600 $1.86 Million
Q1 2021

May 14, 2021

SELL
$71.83 - $95.48 $732,666 - $973,896
-10,200 Reduced 24.82%
30,900 $2.69 Million
Q4 2020

Feb 12, 2021

BUY
$67.0 - $84.39 $603,000 - $759,510
9,000 Added 28.04%
41,100 $2.97 Million
Q3 2020

Nov 13, 2020

BUY
$55.23 - $79.93 $845,019 - $1.22 Million
15,300 Added 91.07%
32,100 $2.51 Million
Q2 2020

Aug 13, 2020

SELL
$30.2 - $56.98 $163,080 - $307,692
-5,400 Reduced 24.32%
16,800 $929,000
Q1 2020

May 11, 2020

SELL
$24.87 - $38.56 $295,953 - $458,864
-11,900 Reduced 34.9%
22,200 $652,000
Q4 2019

Feb 12, 2020

SELL
$25.43 - $36.67 $76,290 - $110,010
-3,000 Reduced 8.09%
34,100 $1.23 Million
Q3 2019

Nov 14, 2019

SELL
$23.0 - $27.97 $409,400 - $497,866
-17,800 Reduced 32.42%
37,100 $1.02 Million
Q2 2019

Aug 20, 2019

BUY
$22.81 - $28.48 $1.25 Million - $1.56 Million
54,900 New
54,900 $1.32 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.